Donate Today Log In

Longevity Medicine Hero

Healthspan · Age-Reversal Science

Extending Human Potential Through
Longevity Medicine

Epigenetic Clocks · Cellular Senescence · Metabolic Optimization · Telomere Health · NAD+ Protocols · Biomarker Panels

Healthspan

Maximized

Precision

Aging Protocols

100%

Personalized Care

Evidence

Based Outcomes

Department Overview

Lon·gev·i·ty
Med·i·
cine

/ länˈjevədē ˈmedəsən / · noun

noun · precision healthspan science

The integration of genomic, epigenetic, and metabolic profiling with advanced aging biomarker diagnostics - moving beyond chronological age to the biological and molecular drivers of cellular aging, healthspan decline, and age-related disease in each individual patient.

Origin

From Latin longaevitas (long life) + medicina (the art of healing). Longevity medicine emerged as epigenetic clocks, single-cell transcriptomics of senescent tissue, and whole-genome sequencing revealed that individuals of the same chronological age harbor profoundly distinct biological ages - requiring individualized diagnostic and therapeutic strategies beyond conventional disease-management protocols to address the upstream molecular drivers of aging itself.

The Longevity Medicine Department at the American Board of Precision Medicine trains clinicians to look beyond standard annual labs and disease screenings - integrating epigenetic age testing, telomere length analysis, senescent cell burden assessment, and NAD+ metabolomics into a molecularly complete picture of each patient's biological age trajectory and healthspan optimization potential.

From mitochondrial dysfunction and mTOR-autophagy pathway dysregulation to inflammaging, epigenetic drift, and pharmacogenomic optimization of senolytic and geroprotective protocols, this department equips physicians with the molecular and metabolic fluency to identify the upstream biological drivers of accelerated aging - and to design individualized interventions that extend healthspan by addressing root causes rather than managing late-stage disease.

Aging is not simply a function of time - it is the downstream expression of a patient's entire genomic, epigenetic, and metabolic architecture. At ABOPM, Longevity Medicine provides the precision framework to decode that architecture for every patient, transforming fragmented biomarker values into a coherent, actionable map of individual biological age and longevity potential.

N=1

Biological Age Profiling

Root

Cause Aging Care

Full

Healthspan Optimization

Longevity Medicine Department · ABOPM

Where Biological Precision Transforms
Healthspan and Human Longevity

The Longevity Medicine Department at ABOPM is redefining aging care — training physicians to move beyond chronological age and disease management protocols, integrating epigenetic clock testing, telomere biology, senescent cell burden assessment, NAD+ metabolomics, and mitochondrial function profiling into a molecularly complete picture of each patient's unique biological age trajectory and healthspan potential.

Biological Age & Epigenetic Profiling

Advancing clinical application of epigenetic clock assessment, telomere length analysis, polygenic longevity risk scoring, senescent cell burden quantification, and pharmacogenomic optimization of geroprotective protocols — enabling physicians to build a molecularly precise biological age portrait for every patient and guide individualized healthspan interventions from first consultation.

Metabolic & Cellular Systems

Bridging molecular geroscience and clinical outcomes — developing board-certified frameworks for mitochondrial function assessment, mTOR-autophagy pathway evaluation, NAD+ metabolomics, inflammaging biomarker profiling, and senolytic protocol optimization to identify and address the upstream biological drivers of accelerated aging and age-related disease before they manifest clinically.

Physician Education

Building the next generation of precision longevity physicians through rigorous board standards, molecular aging literacy training, and interdisciplinary collaboration across clinical genomics, geroscience, metabolic medicine, epigenetics, and translational healthspan research.

"Aging is not simply a function of time — it is the downstream expression of a patient's entire genomic, epigenetic, and metabolic architecture. The Longevity Medicine Department at ABOPM trains physicians to decode that architecture for every patient, transforming fragmented biomarker values into a coherent, actionable map of individual biological age and longevity potential."

American Board of Precision Medicine · Longevity Medicine Department

Become a Member → Support Our Mission → Get Involved →

Longevity Medicine Department · ABOPM

Decoding Each Patient's Biological Age
to Deliver Precision Healthspan and Longevity Care

No two patients age at the same molecular rate. Behind every accelerated aging trajectory, every early-onset age-related disease, and every failed vitality intervention lies a specific biological substrate — epigenetic drift patterns, mitochondrial dysfunction signatures, senescent cell burden profiles, and NAD+ metabolic depletion curves that chronological age metrics and standard annual labs were never designed to resolve. Identifying the molecular architecture of each patient's biological aging process — and matching intervention to that architecture — is not a specialized aspiration; it is the precision obligation of modern longevity medicine.

Precision longevity medicine equips clinicians to move beyond standard disease screening and symptom management and into molecularly stratified healthspan care — applying epigenetic clock assessment, telomere biology profiling, senescent cell burden quantification, and mitochondrial function mapping to identify the upstream biological drivers of accelerated aging and design individualized intervention strategies from the first clinical encounter.

By mastering precision longevity medicine, clinicians gain the power to:

01

Build Each Patient's Biological Age Portrait

Move beyond chronological age and basic metabolic panels to construct a molecularly complete biological age profile — applying epigenetic clock assessment, telomere length analysis, polygenic longevity risk scoring, and senescent cell burden quantification to identify the specific genomic and epigenetic architecture driving each patient's aging trajectory and design targeted healthspan interventions from the first consultation rather than after years of progressive decline.

02

Map Mitochondrial and Metabolic Aging with Molecular Precision

Apply mitochondrial function profiling, NAD+ metabolomics, mTOR-autophagy pathway assessment, and oxidative stress biomarker analysis to identify the specific bioenergetic and metabolic network disruptions driving cellular aging, energy depletion, and tissue dysfunction — enabling mechanistically targeted interventions that restore mitochondrial health and metabolic resilience at the molecular level rather than masking symptoms with broad supplementation.

03

Profile Inflammaging and Senescent Cell Burden

Integrate inflammaging cytokine panel analysis, senescent cell burden assessment, SASP factor profiling, and immune senescence mapping to characterize the inflammatory biology driving accelerated tissue aging and chronic disease risk — identifying patient-specific senolytic and anti-inflammaging intervention targets that predict treatment response and guide precision geroprotective strategies with molecular accuracy.

04

Apply PGx-Optimized Geroprotective and Senolytic Protocols

Use pharmacogenomic profiling of drug-metabolizing enzyme variants, mTOR pathway polymorphisms, and senolytic drug transporter genetics to individualize rapamycin, metformin, NAD+ precursor, and senolytic protocol selection and dosing — eliminating adverse responses and subtherapeutic outcomes through genotype-guided geroprotective therapy while maximizing biological age reversal potential for each individual patient.

05

Lead Precision Longevity Medicine at Your Institution

Become the molecular longevity authority your institution needs — the physician who builds genomically grounded biological age programs, leads epigenetic rejuvenation and healthspan optimization clinics, and creates the institutional infrastructure for precision longevity care that moves patients from reactive disease management to molecularly individualized strategies that maximize healthspan and vitality from the first intervention.

Why Longevity Medicine Certification Is Non-Negotiable

Every patient has a biological age. The question is, are you equipped to decode it?

Precision-Driven Outcomes

Molecularly stratified longevity care consistently outperforms empirical supplementation and lifestyle protocols — delivering measurably better biological age reversal, fewer accelerated aging trajectories, and reduced disease burden by identifying and addressing the specific molecular drivers of each patient's aging process from the first clinical decision rather than discovering them through years of costly trial and error.

Future-Ready Practice

Epigenetic reprogramming, senolytics, AI-guided biological age reversal, partial cellular rejuvenation, and precision NAD+ restoration are transforming longevity medicine — physicians board-certified in precision longevity medicine will define the next generation of molecularly individualized healthspan care and lead the clinical translation of aging science into patient outcomes.

Clinical Authority

Board certification in precision longevity medicine marks you as the biological age and molecular healthspan authority — a physician equipped to lead complex aging reversal programs, precision geroprotective optimization clinics, and institutional longevity medicine initiatives grounded in molecular geroscience rather than empirical wellness protocol application.

Cross-System Impact

Precision longevity medicine principles span cardiovascular aging, neurocognitive decline, metabolic disease, musculoskeletal deterioration, immune senescence, and hormonal aging — giving you a molecularly grounded framework to address biological aging and healthspan optimization across every organ system and every clinical presentation you encounter throughout the lifespan.

Active research areas driving longevity medicine forward:

01

Epigenetic Clock Validation & Biological Age Assessment

Advancing the construction and clinical validation of next-generation epigenetic aging clocks — characterizing the DNA methylation patterns, histone modification signatures, chromatin remodeling dynamics, and transcriptomic aging trajectories that predict biological age acceleration, age-related disease onset, and healthspan decline, building the evidence base for epigenetic age-guided clinical decision-making that replaces chronological age assumptions with molecularly precise biological age stratification for every patient.

02

Senescence Biology & Senolytic Protocol Development

Developing molecularly coherent senescent cell burden classification frameworks and evidence-based senolytic intervention protocols — applying p16INK4a expression quantification, SASP factor profiling, tissue-specific senescence biomarker panels, and pharmacogenomic senolytic response prediction to define biologically distinct senescence burden phenotypes that guide individualized dasatinib, quercetin, fisetin, and navitoclax protocol selection matched to the specific cellular aging architecture of each patient.

03

Mitochondrial Function & NAD+ Metabolomics

Advancing the molecular characterization of mitochondrial aging biology — applying mitochondrial membrane potential assessment, mtDNA copy number analysis, oxidative phosphorylation complex profiling, NAD+ metabolomics, and SIRT1/AMPK pathway activity quantification to identify the patient-specific bioenergetic signatures of cellular aging that predict healthspan trajectory and guide precision mitochondrial restoration and NAD+ repletion intervention strategies grounded in each patient's specific metabolic aging biology.

04

Inflammaging Biomarkers & Immune Senescence Profiling

Characterizing the immunological determinants of accelerated biological aging — advancing inflammaging cytokine panel development, thymic output assessment, T-cell senescence and exhaustion profiling, NK cell functional decline quantification, and inflammasome activation biomarker methods that identify the molecular signatures of immune aging driving chronic disease risk and cognitive decline, enabling precision anti-inflammaging and immune rejuvenation intervention strategies grounded in each patient's specific immune senescence biology.

05

Pharmacogenomics of Geroprotective Therapy

Building the pharmacogenomic evidence base for individualized geroprotective protocol design — characterizing mTOR pathway polymorphisms, AMPK activator response variants, CYP enzyme profiles affecting rapamycin and metformin metabolism, and telomerase pathway genetics that predict geroprotective drug efficacy, biological age reversal response, and adverse event risk, enabling PGx-guided longevity protocol design that optimizes healthspan extension outcomes while eliminating genotype-predictable treatment complications before they occur.

Longevity Medicine Research · ABOPM

Decoding the Molecular Biology of Biological Aging and Healthspan

The precision longevity medicine revolution is not a future event — it is rewriting how aging is assessed and addressed today. Epigenetic clock validation, senolytic protocol development, mitochondrial NAD+ restoration, inflammaging biomarker profiling, and pharmacogenomic geroprotective optimization are actively transforming how every aging trajectory and age-related disease risk is diagnosed, stratified, and therapeutically addressed at the molecular and individual patient level.

The ABOPM Longevity Medicine Department positions clinicians at the center of this transformation — equipping them with the molecular aging literacy, epigenetic and senescence biology frameworks, and board-certified credentials to lead precision longevity medicine programs across every biological age presentation and healthspan optimization domain.

20+

Years gap between lifespan and healthspan in most patients

3x

Biological age variation between same-age individuals

PGx

Guided geroprotective dosing replacing empirical longevity protocols

Explore Blog Topics → Read clinical insights, case studies & longevity medicine updates on our blog

Longevity Medicine Department · ABOPM

Meet Our Leadership

Director of Longevity Medicine

Director

Longevity Medicine

Director of Longevity Medicine CEO & CMO · PhysioAge Health Analytics

Joseph Raffaele, MD

Longevity Physician · Telomere Biology · Epigenetics · Hormone Therapy · Precision Aging Analytics · 25 Years in Longevity Medicine

"Practicing precision, n-of-1 longevity medicine for 25 years — applying telomere biology, epigenetics, hormone therapy, and glycobiology to decode each patient's unique biological aging trajectory and deliver individualized interventions that measurably extend healthspan."

Dr. Joseph Raffaele has been practicing longevity medicine for 25 years and has published clinical studies in telomere biology, epigenetics, hormone therapy, and glycobiology. He is the CEO and CMO of PhysioAge Health Analytics — a software company he co-founded that enables longevity practices around the world to practice precision, n-of-1 longevity medicine more effectively than traditional EHRs, delivering individualized biological age analytics at the point of care.

Dr. Raffaele routinely writes about longevity medicine on Raffaelemedical.com, PhysioAge.com, and @RaffaeleMD — sharing clinical insights, research updates, and precision aging frameworks with physicians and patients navigating the frontier of healthspan science. His work bridges rigorous clinical research and practical longevity medicine, making him one of the most experienced precision aging physicians practicing today.

25

Years in Longevity Medicine

N=1

Precision Aging Analytics Platform

Pub.

Telomere, Epigenetic & Hormone Research

Connect on LinkedIn

Faculty Members

Our faculty roster is growing — announcements coming soon.

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Think you're the right fit for a faculty position?

Get Involved →

Genomics Department · ABOPM

Shaping the Future
of Precision Medicine

As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.

The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.

Explore Certification → Get Involved

Featured Insights

Insights Shaping
Precision Medicine

Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Multi-Omics Clinical Innovation Precision Prevention Physician Leadership

Liquid Biopsy and Early Cancer Detection: Promise and Limitations

Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring. ...more

Precision Oncology

June 05, 2026•9 min read

Polygenic Risk Scores and the Genomic Data Gap: Promise, Limitations, and Equity in Precision Medicine

Polygenic risk scores may transform disease prediction, but gaps in genomic diversity continue to limit equity, accuracy, and access in precision medicine across global populations. ...more

Population Precision

May 26, 2026•9 min read

Artificial Intelligence in Precision Medicine

Artificial intelligence is reshaping precision medicine by improving diagnostics, predicting treatment response, and enabling more personalized, data-driven healthcare strategies. ...more

On the Frontier

May 20, 2026•9 min read